Couples in HIV serodiscordant relationships frequently desire children. Although partners who are virally suppressed pose almost no risk of transmitting HIV to their partners, partners who are inconsistently on therapy may transmit HIV to their partners when attempting to conceive. Pre-exposure prophylaxis (PrEP) is an available safer conception strategy for these couples but is not consistently offered. We sought to better understand barriers to PrEP implementation for couples seeking conception and patient perceptions on what providers could do to encourage use. We conducted in-depth, qualitative interviews with 11 participants representing six couples taking PrEP for safer conception in a safety-net hospital in New England. Semi-structur...
Safer conception services are needed to minimize HIV transmission among HIV sero-different couples d...
The FDA approved pre-exposure prophylaxis (PrEP) with Truvada® in 2012 as the first drug to reduce t...
Objective: We conducted a mixed-methods study to examine serodiscordant and seroconcordant (HIV-posi...
Understanding HIV-infected patient experiences and perceptions of reproductive counseling in the hea...
Introduction: We explored acceptability and feasibility of safer conception methods among HIV-affect...
Safer conception strategies to reduce HIV transmission risk include antiretroviral therapy (ART) for...
Introduction: Safer conception strategies create opportunities for HIV-serodiscordant couples to rea...
It is estimated that there are 140,000 heterosexual serodiscordant couples in the United States. Giv...
Safer conception services are needed to minimize HIV transmission among HIV sero-different couples d...
Introduction: For HIV serodiscordant couples in resource-limited settings, pregnancy is common despi...
Safer conception services are needed to minimize HIV transmission among HIV sero-different couples d...
To describe the development and implementation of a safer conception service in a resource-limited s...
We explored acceptability and feasibility of safer conception methods among HIV-affected couples in ...
Introduction: Implementation of safer conception services for HIV-affected couples within primary he...
Safer conception services are needed to minimize HIV transmission among HIV sero-different couples d...
Safer conception services are needed to minimize HIV transmission among HIV sero-different couples d...
The FDA approved pre-exposure prophylaxis (PrEP) with Truvada® in 2012 as the first drug to reduce t...
Objective: We conducted a mixed-methods study to examine serodiscordant and seroconcordant (HIV-posi...
Understanding HIV-infected patient experiences and perceptions of reproductive counseling in the hea...
Introduction: We explored acceptability and feasibility of safer conception methods among HIV-affect...
Safer conception strategies to reduce HIV transmission risk include antiretroviral therapy (ART) for...
Introduction: Safer conception strategies create opportunities for HIV-serodiscordant couples to rea...
It is estimated that there are 140,000 heterosexual serodiscordant couples in the United States. Giv...
Safer conception services are needed to minimize HIV transmission among HIV sero-different couples d...
Introduction: For HIV serodiscordant couples in resource-limited settings, pregnancy is common despi...
Safer conception services are needed to minimize HIV transmission among HIV sero-different couples d...
To describe the development and implementation of a safer conception service in a resource-limited s...
We explored acceptability and feasibility of safer conception methods among HIV-affected couples in ...
Introduction: Implementation of safer conception services for HIV-affected couples within primary he...
Safer conception services are needed to minimize HIV transmission among HIV sero-different couples d...
Safer conception services are needed to minimize HIV transmission among HIV sero-different couples d...
The FDA approved pre-exposure prophylaxis (PrEP) with Truvada® in 2012 as the first drug to reduce t...
Objective: We conducted a mixed-methods study to examine serodiscordant and seroconcordant (HIV-posi...